TCM
NEO icon

Tygh Capital Management’s NeoGenomics NEO Stock Holding History

Tygh Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-159,678
Closed -$7.7M – 94
2021
Q3 		$7.7M Sell
159,678
-95,863
-38% -$4.44M 1.04% 47
2021
Q2 		$11.5M Buy
255,541
+136,223
+114% +$6.04M 1.57% 23
2021
Q1 		$5.75M Buy
119,318
+34,142
+40% +$1.78M 0.81% 56
2020
Q4 		$4.59M Buy
85,176
+568
+0.7% +$25.7K 0.71% 65
2020
Q3 		$3.12M Sell
84,608
-33,193
-28% -$1.23M 0.59% 65
2020
Q2 		$3.65M Buy
+117,801
New +$3.26M 0.76% 60

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tygh Capital Management's NEO Position: Q4 2021 in Review

Tygh Capital Management sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 159,678 shares — an estimated $7.7M sold.

Tygh Capital Management first reported a position in NEO in Q2 2020 and held it in 6 quarters. The position peaked at $11.5M in Q2 2021. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Tygh Capital Management reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Tygh Capital Management sold 159,678 NeoGenomics shares in Q4 2021, an estimated $7.7M.
  • Tygh Capital Management first reported a position in NeoGenomics in Q2 2020 and held it in 6 quarters.
  • Tygh Capital Management's NeoGenomics position peaked at $11.5M in Q2 2021.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.